Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2026)

Camp4 Therapeutics has reported Net Cash Flow for 4 years, with the latest figure at -$10.9 million in Q1 2026.

• Quarterly Net Cash Flow rose 25.77% year-over-year to -$10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.9 million (up 123.67% YoY) and the FY2025 annual result came in at $46.1 million, up 79.64% from the prior year.
• Net Cash Flow retreated to -$10.9 million in Q1 2026 per CAMP's latest filing, from $34.8 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $61.5 million in Q4 2024 and troughed at -$14.7 million in Q1 2025.
• A 4-year average of $4.9 million and a median of -$10.6 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow soared 608.82% in 2024, then sank 43.37% in 2025.
• Over 4 years, Net Cash Flow stood at -$12.1 million in 2023, then jumped by 608.82% to $61.5 million in 2024, then plunged by 43.37% to $34.8 million in 2025, then tumbled by 131.36% to -$10.9 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$10.9 million, $34.8 million, and $36.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.